The U.S. FDA begins inspecting Samsung BioLogics' Songdo production facilities.

The Food and Drug Administration (FDA) is inspecting the production facilities of Samsung BioLogics. Samsung BioLogics stated, "We cannot comment on the matter due to the related diligence being client-specific," but added that the diligence is not related to the US government's "Overseas Inspection Pilot Program."